Skip to content

White Paper on OSSIOfiber Technology

← All Posts

Our proprietary material technology, OSSIOfiber® Intelligent Bone Regeneration Technology, has unique material composition and structural design that contribute to its strength and optimal bio-integration for orthopedic fixation. Scientific and clinical leaders at OSSIO discuss the science behind OSSIOfiber in this Technology Overview White Paper. 

Key Takeaways:

  • OSSIOfiber material composition creates the ideal bone fixation material that supports mechanical strength and balanced pH environment favorable for bone regeneration
  • The micro-architecture of thousands of continuous natural mineral fibers is engineered to create the optimal biomechanical properties in different mechanical axes for the clinical indications
  • As OSSIOfiber implants degrade, interconnected pores are formed allowing for fluid flow and regeneration of bone tissue in place of the implant
Screen Shot 2020-10-30 At 1.38.34 Pm

Through the material composition and internal architecture, OSSIOfiber is designed to provide both the mechanical strength required for insertion and secure fixation while having the ability to integrate into native bone without adverse inflammation. In doing so, OSSIOfiber Intelligent Bone Regeneration Technology creates a new category of fixation, called ‘Bio-Integratives’.

 

Learn more about material composition and structural design of OSSIOfiber Intelligent Bone Regeneration Technology.

 

Orahn Preiss-Bloom, Founder and Chief Innovation Officer

Orahn Preiss-Bloom, Founder and Chief Innovation Officer

Orahn is the Founder and Chief Innovation Officer at OSSIO. Previously, as founder and COO/CTO of LifeBond, Orahn developed two biosurgical product families to commercial stage and raised $60M, including from Johnson & Johnson Development Corporation. Prior, he was a biomechanics researcher at IDF Institute for Military Physiology and at Columbia University NY, Dept. of Orthopedic Surgery. Orahn has an M.Sc. in biomedical engineering from the Technion, Israel Institute of Technology.

Related Posts

Pediatric Carpal Coalition Symptomatic Synchondrosis Revision Fusion

Author: Jue Cao, MD, FAAOS., HCA HealthONE Rocky Mountain Children’s Hospital, Denver, CO INTRODUCTION Carpal coalitions is a rare anatomical abnormality, characterized by the union of two or more carpal bones and caused by a defect in the separation and cavitation process during embryonic development. As most patients with congenital carpal coalitions are asymptomatic andContinue reading “Pediatric Carpal Coalition Symptomatic Synchondrosis Revision Fusion”

Jue Cao, MD, FAAOS., HCA HealthONE Rocky Mountain Children’s Hospital, Denver, CO January 20, 2026

Biointegrative Fixation for Tibial Tubercle Osteotomy Is Effective and May Lower Removal Rate

Scott M. Feeley, M.D., Rehan Dawood, D.O., Parth Sharma, B.S., Jamie M. Mwendwa, B.S., Christopher M. Kuenze, Ph.D., Edward S. Chang, M.D., and Brandon J. Bryant, M.D. From the Department of Orthopaedic Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, U.S.A. (S.M.F.); Inova Sports Medicine, Fairfax, Virginia, U.S.A. (R.D., P.S., E.S.C., B.J.B.); Villanova University,Continue reading “Biointegrative Fixation for Tibial Tubercle Osteotomy Is Effective and May Lower Removal Rate”

Brandon J. Bryant, M.D.

All-Natural Flatfoot Reconstruction

Author: Bradley W. Lind, DPM, FACFAS, Ryan Foot and Ankle Specialists-Charlotte, NC. Dr. Bradley W. Lind is a board-certified surgeon in Charlotte, North Carolina who specializes in complex deformity correction of the foot and ankle. An all-natural approach is provided to his patients, when possible, using biointegrative products. He is passionate about providing his patientsContinue reading “All-Natural Flatfoot Reconstruction”

Bradley W. Lind, DPM, FACFAS, Ryan Foot and Ankle Specialists-Charlotte, NC July 3, 2025

Interested in OSSIOfiber®?

Complete the form and an OSSIOfiber® Advisor will get in touch.

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email info@ossio.io

Address

Commercial Headquarters
OSSIO Inc
300 Tradecenter Drive, Suite 3690
Woburn, MA, 01801

Science & Manufacturing Center

OSSIO Ltd.
8 HaTochen Street
Cesarea, Israel 3079861

OSSIOfiber® has been used by 2200+ surgeons across the US

Footnotes

1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO. 5.Haddad, S. F., Helm, M. M., Meath, B., Adams, C., Packianathan, N., & Uhl, R. (2019). Exploring the Incidence, Implications, and Relevance of Metal Allergy to Orthopaedic Surgeons. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 3(4), e023. https://doi.org/10.5435/JAAOSGlobal-D-19-00023